- Home
- CTMX vs SIFY Comparison
CTMX vs SIFY Comparison
Compare CTMX & SIFY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CTMX
- SIFY
- Stock Information
- Founded
- CTMX 2008
- SIFY 1995
- Country
- CTMX United States
- SIFY India
- Employees
- CTMX N/A
- SIFY N/A
- Industry
- CTMX Biotechnology: Pharmaceutical Preparations
- SIFY Computer Software: Programming Data Processing
- Sector
- CTMX Health Care
- SIFY Technology
- Exchange
- CTMX Nasdaq
- SIFY Nasdaq
- Market Cap
- CTMX 444.3M
- SIFY 369.1M
- IPO Year
- CTMX 2015
- SIFY 1999
- Fundamental
- Price
- CTMX $2.40
- SIFY $5.55
- Analyst Decision
- CTMX Strong Buy
- SIFY
- Analyst Count
- CTMX 2
- SIFY 0
- Target Price
- CTMX $5.00
- SIFY N/A
- AVG Volume (30 Days)
- CTMX 1.5M
- SIFY 72.4K
- Earning Date
- CTMX 08-07-2025
- SIFY 07-18-2025
- Dividend Yield
- CTMX N/A
- SIFY N/A
- EPS Growth
- CTMX 128.27
- SIFY N/A
- EPS
- CTMX 0.49
- SIFY N/A
- Revenue
- CTMX $147,557,000.00
- SIFY $480,237,627.00
- Revenue This Year
- CTMX N/A
- SIFY N/A
- Revenue Next Year
- CTMX N/A
- SIFY $13.46
- P/E Ratio
- CTMX $4.97
- SIFY N/A
- Revenue Growth
- CTMX 23.81
- SIFY 12.82
- 52 Week Low
- CTMX $0.40
- SIFY $1.84
- 52 Week High
- CTMX $3.10
- SIFY $5.95
- Technical
- Relative Strength Index (RSI)
- CTMX 51.91
- SIFY 62.11
- Support Level
- CTMX $2.32
- SIFY $4.84
- Resistance Level
- CTMX $2.47
- SIFY $5.95
- Average True Range (ATR)
- CTMX 0.14
- SIFY 0.36
- MACD
- CTMX -0.01
- SIFY 0.06
- Stochastic Oscillator
- CTMX 17.89
- SIFY 71.43
About CTMX CytomX Therapeutics Inc.
CytomX Therapeutics Inc a clinical-stage, oncology-focused biopharmaceutical company developing novel, masked, conditionally activated biologics designed to be localized to the tumor microenvironment. It is engaged in developing antibody therapeutics based on probody technology platforms. The company's probody technology platform creates proprietary cancer immunotherapies against clinically-validated targets and develops cancer therapeutics. Probody therapeutics are designed to take advantage of conditions in the tumor microenvironment to enhance the tumor-targeting features of an antibody and reduce drug activity in healthy tissues.
About SIFY Sify Technologies Limited
Sify Technologies Ltd is a provider of corporate network services in India. It offers converged Information and Communication Technology (ICT) solutions comprising Network- Connectivity services, Data Center services and Digital Services which include Cloud and Managed services, Applications Integration services and Technology Integration services. The company operates in three segments; Network Connectivity services which consists of domestic data, international data, wholesale voice. Data Center Services which consists of co-location services, cross connects and other allied managed services. Digital Services which consists of Cloud and Managed Services, Network Managed Services, Applications Integration Services, Technology Integration Services. Key revenue is from Network.